Delivery Order SPE2DB24D2010-SPE2DB25FZUB5

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTEZLA 30 MG TABLET 60S, a specialty medication. The $4,719.21 firm-fixed-price delivery order has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,945.21 firm fixed-price delivery order contract is for the supply of OTEZLA 30 MG TABLET 60S, with a completion date of June 23, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,563.93 firm fixed-price delivery order covers the supply of OTEZLA 30 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,826.40 firm-fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a specialty medication. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,985.78 firm-fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a prescription medication, with a period of performance through December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves...
This federal contract award, valued at $7,765.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,951.84 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a prescription medication. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $7,050.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a medication, with a completion date of December 4, 2024. It is a firm-fixed-price delivery order contract, indicating the pricing is predetermined. The contract does not have a set-aside designation, suggesting open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,504.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a specialty medication, with a completion date of December 18, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTEZLA 30 MG TABLET 60S. The delivery order, valued at $8,538.08, has a firm fixed price and a period of performance through September 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZUB5
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,465.48, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 10:05 AM